MedTrace Logo

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

NCT01077557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2017-06-01

No results posted yet for this study

Summary

This US population-based study will explore the incidence of and risks for fracture among adults with and without human immunodeficiency virus (HIV) infection. The objectives are to determine the incidence of fracture among persons with and without HIV infection, compare risk factors for fracture among persons with and without HIV infection, and to examine the associations of antiretroviral (ARV) treatment exposure for incidence and risk of fracture among persons with HIV infection.

Conditions

  • Fracture
  • Infection, Human Immunodeficiency Virus

Interventions

OTHER

No Antiretroviral (ARV) Drug Exposure

No pharmacy dispensing of an ARV drug

DRUG

Any Antiretroviral (ARV) Drug Exposure

Pharmacy dispensing claim for any ARV drug

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · ViiV Healthcare

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2011-11-30
Completion
2011-11-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01077557 on ClinicalTrials.gov